Andrzej Jakubowiak to Patient Reported Outcome Measures
This is a "connection" page, showing publications Andrzej Jakubowiak has written about Patient Reported Outcome Measures.
Connection Strength
0.232
-
Health-related quality of life in patients with newly diagnosed multiple myeloma ineligible for stem cell transplantation: results from the randomized phase III ALCYONE trial. BMC Cancer. 2021 Jun 02; 21(1):659.
Score: 0.182
-
Longitudinal Real-World Neuropathy and Patient-Reported Outcomes With Bortezomib and Lenalidomide in Newly Diagnosed Multiple Myeloma. Clin Lymphoma Myeloma Leuk. 2022 11; 22(11):e1000-e1008.
Score: 0.049